Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 24% ± 7% | |
ciliated cell | 3 studies | 17% ± 1% |
Insufficient scRNA-seq data for expression of BSPRY at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 3018.22 | 328 / 328 | 92% | 32.07 | 163 / 178 |
thymus | 100% | 3409.79 | 653 / 653 | 88% | 87.01 | 531 / 605 |
prostate | 78% | 616.91 | 190 / 245 | 98% | 33.43 | 493 / 502 |
stomach | 76% | 2331.18 | 272 / 359 | 94% | 43.79 | 268 / 286 |
lung | 80% | 630.00 | 464 / 578 | 82% | 32.92 | 951 / 1155 |
breast | 58% | 922.56 | 266 / 459 | 99% | 88.25 | 1104 / 1118 |
kidney | 100% | 1343.52 | 89 / 89 | 41% | 10.35 | 372 / 901 |
intestine | 43% | 608.77 | 412 / 966 | 98% | 63.58 | 514 / 527 |
esophagus | 39% | 1243.07 | 558 / 1445 | 68% | 18.75 | 124 / 183 |
ureter | 0% | 0 | 0 / 0 | 100% | 29.66 | 1 / 1 |
bladder | 24% | 134.38 | 5 / 21 | 75% | 34.70 | 379 / 504 |
ovary | 0% | 0 | 0 / 180 | 89% | 24.34 | 382 / 430 |
adrenal gland | 59% | 322.38 | 151 / 258 | 29% | 6.71 | 67 / 230 |
tonsil | 0% | 0 | 0 / 0 | 84% | 28.22 | 38 / 45 |
skin | 72% | 2207.78 | 1304 / 1809 | 5% | 1.16 | 22 / 472 |
uterus | 4% | 31.65 | 7 / 170 | 71% | 31.95 | 328 / 459 |
brain | 47% | 693.51 | 1252 / 2642 | 1% | 0.11 | 6 / 705 |
lymph node | 0% | 0 | 0 / 0 | 41% | 12.68 | 12 / 29 |
liver | 1% | 7.04 | 3 / 226 | 19% | 5.47 | 78 / 406 |
peripheral blood | 16% | 106.68 | 150 / 929 | 0% | 0 | 0 / 0 |
heart | 5% | 21.71 | 44 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.30 | 1 / 80 |
adipose | 0% | 4.91 | 5 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 2.18 | 4 / 1335 | 0% | 0 | 0 / 0 |
muscle | 0% | 1.18 | 2 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
GO_1990830 | Biological process | cellular response to leukemia inhibitory factor |
GO_0016567 | Biological process | protein ubiquitination |
GO_0006816 | Biological process | calcium ion transport |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0031252 | Cellular component | cell leading edge |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0046872 | Molecular function | metal ion binding |
Gene name | BSPRY |
Protein name | B box and SPRY domain-containing protein |
Synonyms | |
Description | FUNCTION: May regulate epithelial calcium transport by inhibiting TRPV5 activity. . |
Accessions | ENST00000374183.5 [Q5W0U4-1] Q5W0U4 |